Cognitive tests for the detection of mild cognitive impairment (MCI), the prodromal stage of dementia: Meta‐analysis of diagnostic accuracy studies

  title={Cognitive tests for the detection of mild cognitive impairment (MCI), the prodromal stage of dementia: Meta‐analysis of diagnostic accuracy studies},
  author={Alexandre Breton and Daniel Casey and Nikitas A. Arnaoutoglou},
  journal={International Journal of Geriatric Psychiatry},
  pages={233 - 242}
Mild cognitive impairment (MCI) is regarded as a prodrome to dementia. Various cognitive tests can help with diagnosis; meta‐analysis of diagnostic accuracy studies would assist clinicians in choosing optimal tests. 

Validation study of the Alzheimer's Disease Assessment Scale‐Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities

The validity of the Chinese version of Alzheimer's Disease Assessment Scale‐Cognitive Subscale (ADAS‐Cog) for the community‐dwelling older people in China is verified.

Cognitive screening instruments to identify vascular cognitive impairment: A systematic review

This work systematically reviewed the psychometric properties of brief CSIs for vascular mild cognitive impairment (VMCI) and vascular dementia (VaD) and found them to be suitable for VCI.

Active case finding of dementia in ambulatory care settings: a comparison of three strategies

  • T. Liew
  • Psychology, Medicine
    European journal of neurology
  • 2020
This diagnostic study compared the performance of the three strategies for detecting dementia (primary aim), as well as for detecting both mild cognitive impairment (MCI) and dementia (secondary aim).

Comparing the Diagnostic Accuracy of Two Cognitive Screening Instruments in Different Dementia Subtypes and Clinical Depression

The SMMSE is less suitable in MCI, vascular and Parkinson’s dementia, where alternatives including the Qmci screen may be used, and the influence of co-morbid depression on scores merits further investigation.

Brief Cognitive Tests Used in Primary Care Cannot Accurately Differentiate Mild Cognitive Impairment from Subjective Cognitive Decline

There is a great need to further develop, validate, and implement accurate screening-tests for primary care to improve accurate identification of MCI among individuals that seek medical care due to cognitive symptoms.

Utility of Diffusion Modeling of Cogstate Brief Battery Test Performance in Detecting Mild Cognitive Impairment.

Traditional Cogstate measures of recognition learning and working memory accuracy and diffusion modeling variable of decision-making efficiency and nondecisional time were most predictive of MCI, but participants with MCI did not evidence this change.

Predicting Cognitive Decline and Dementia with the Newly Normed SKT Short Cognitive Performance Test

The newly normed SKT showed a high predictive validity for the onset of dementia, based on Kaplan-Meier estimators, and the trajectories of the different SKT traffic light labels were investigated over 3 years.

Preventing dementia? Interventional approaches in mild cognitive impairment

Symptom clusters of subjective cognitive decline amongst cognitively normal older persons and their utilities in predicting objective cognitive performance: structural equation modelling

How the memory and non‐memory complaints ofSCD cluster with each other amongst community‐dwelling individuals was investigated, and the differential utility of the symptom clusters of SCD in predicting objective cognitive performance was evaluated.

Random Forest Model in the Diagnosis of Dementia Patients with Normal Mini-Mental State Examination Scores

This simplified cognitive assessment model can be useful for the diagnosis of MCI and dementia in patients with normal MMSE, and not only optimizes the content of cognitive evaluation, but also improves diagnosis and reduces missed diagnosis.



The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

A 10‐minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first‐line physicians in detection of mild cognitive impairment (MCI), a clinical state that often progresses to dementia.

Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population

To design and validate a new screening test for amnestic Mild Cognitive Impairment (A‐MCI) and early stage Alzheimer's disease (AD).

Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies

The objective of this study is to quantify the risk of developing dementia in those with mild cognitive impairment (MCI) and to establish a biomarker for dementia in these patients.

The prevalence of mild cognitive impairment about elderly population in China: a meta‐analysis

  • H. NieYong Xu Yan Wu
  • Psychology, Medicine
    International journal of geriatric psychiatry
  • 2011
A systematic analysis of the prevalence of mild cognitive impairment in China found that it is higher in the rural areas than in the urban areas, and the prevalence is higher for women.

The Mini‐Cog as a Screen for Dementia: Validation in a Population‐Based Sample

The Mini‐Cog, a brief cognitive screening test, is tested in an epidemiological study of dementia in older Americans and shows promise as a screening test for Alzheimer's disease.

The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening

There is a clear need for brief, but sensitive and specific, cognitive screening instruments as evidenced by the popularity of the Addenbrooke's Cognitive Examination (ACE).

Mild cognitive impairment

A philosophical analysis of MCI is offered from epistemological, ethical and semantic perspectives and it is believed that the term should currently not be used clinically.

Exploring the validity of mild cognitive impairment (MCI) subtypes: Multiple-domain amnestic MCI is the only identifiable subtype at longitudinal follow-up

The findings suggest that the a-MCI+ subtype is the only variant that is recognizable via neuropsychological testing and the differentiation between single-domain subtypes and healthy controls is difficult and may not be achievable through current Neuropsychological assessment practices.

Mild cognitive impairment as a diagnostic entity

  • R. Petersen
  • Psychology, Medicine
    Journal of internal medicine
  • 2004
It is suggested that the diagnosis of mild cognitive impairment can be made in a fashion similar to the clinical diagnoses of dementia and AD, and an algorithm is presented to assist the clinician in identifying subjects and subclassifying them into the various types of MCI.

Recall Tests Are Effective to Detect Mild Cognitive Impairment: A Systematic Review and Meta-analysis of 108 Diagnostic Studies.

  • K. TsoiJ. Chan S. Wong
  • Medicine, Psychology
    Journal of the American Medical Directors Association
  • 2017